Immunic Change In Cash vs Capital Expenditures Analysis

IMUX Stock

USD 1.10 0.01 0.90%

Immunic financial indicator trend analysis is infinitely more than just investigating Immunic recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunic is a good investment. Please check the relationship between Immunic Change In Cash and its Capital Expenditures accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.

Change In Cash vs Capital Expenditures

Change In Cash vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunic Change In Cash account and Capital Expenditures. At this time, the significance of the direction appears to have no relationship.

The correlation between Immunic's Change In Cash and Capital Expenditures is 0.07. Overlapping area represents the amount of variation of Change In Cash that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Immunic, assuming nothing else is changed. The correlation between historical values of Immunic's Change In Cash and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change In Cash of Immunic are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Change In Cash i.e., Immunic's Change In Cash and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

0.07

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Change In Cash

Capital Expenditures

Capital Expenditures are funds used by Immunic to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Immunic operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from Immunic's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunic current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Immunic Stock please use our How to Invest in Immunic guide.Selling General Administrative is likely to drop to about 14 M in 2024. Issuance Of Capital Stock is likely to drop to about 810.4 K in 2024

	2021	2022	2023	2024 (projected)
Net Interest Income	66K	1.0M	3.1M	3.2M
Interest Income	66K	1.0M	3.1M	3.2M

Net Interest Income Interest Income

Immunic fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Short Term Investments	Non Currrent Assets Other	Common Stock Total Equity	Common Stock	Net Tangible Assets	Retained Earnings Total Equity
Total Assets		0.31	0.32	0.39	0.96	0.21	-0.95	-0.04	0.57	0.96	0.6	0.96	0.41	-0.62	0.7	0.33	-0.53	0.21	0.97	-0.23	-0.48	-0.53	0.28	0.28	0.34	0.05
Short Long Term Debt Total	0.31		0.62	0.69	0.21	-0.04	-0.31	-0.58	0.2	0.34	-0.16	0.37	0.82	-0.22	0.4	0.56	0.05	-0.04	0.39	-0.03	0.06	-0.45	0.56	0.56	0.47	-0.51
Other Current Liab	0.32	0.62		0.97	0.22	0.23	-0.33	-0.62	0.43	0.4	-0.19	0.39	0.82	-0.45	0.32	0.46	-0.09	0.23	0.4	-0.2	-0.43	-0.47	0.64	0.65	0.3	-0.57
Total Current Liabilities	0.39	0.69	0.97		0.27	0.09	-0.34	-0.6	0.39	0.41	0.0	0.4	0.91	-0.46	0.42	0.45	-0.08	0.09	0.42	-0.07	-0.42	-0.56	0.57	0.58	0.31	-0.46
Total Stockholder Equity	0.96	0.21	0.22	0.27		0.28	-0.94	-0.04	0.55	0.93	0.59	0.92	0.26	-0.75	0.64	0.38	-0.73	0.28	0.93	-0.14	-0.6	-0.55	0.33	0.32	0.18	0.03
Property Plant And Equipment Net	0.21	-0.04	0.23	0.09	0.28		-0.43	0.06	0.67	0.42	-0.38	0.41	-0.19	-0.34	-0.15	0.04	-0.35	1.0	0.37	-0.58	-0.32	0.24	0.19	0.19	0.17	-0.11
Net Debt	-0.95	-0.31	-0.33	-0.34	-0.94	-0.43		0.03	-0.68	-0.99	-0.39	-0.99	-0.29	0.63	-0.55	-0.34	0.56	-0.43	-0.98	0.34	0.49	0.44	-0.36	-0.36	-0.36	0.05
Retained Earnings	-0.04	-0.58	-0.62	-0.6	-0.04	0.06	0.03		0.13	-0.07	0.24	-0.07	-0.64	0.4	-0.23	-0.88	0.19	0.06	-0.09	-0.15	0.3	0.64	-0.83	-0.84	0.12	0.86
Accounts Payable	0.57	0.2	0.43	0.39	0.55	0.67	-0.68	0.13		0.69	0.03	0.67	0.21	-0.44	0.2	-0.03	-0.33	0.67	0.65	-0.33	-0.41	-0.18	0.24	0.24	0.3	0.01
Cash	0.96	0.34	0.4	0.41	0.93	0.42	-0.99	-0.07	0.69		0.38	0.99	0.36	-0.64	0.55	0.35	-0.54	0.42	0.99	-0.34	-0.5	-0.47	0.38	0.38	0.36	-0.08
Non Current Assets Total	0.6	-0.16	-0.19	0.0	0.59	-0.38	-0.39	0.24	0.03	0.38		0.35	0.12	-0.27	0.57	0.02	-0.3	-0.38	0.39	0.27	-0.33	-0.43	-0.19	-0.2	-0.03	0.53
Cash And Short Term Investments	0.96	0.37	0.39	0.4	0.92	0.41	-0.99	-0.07	0.67	0.99	0.35		0.37	-0.63	0.56	0.35	-0.53	0.41	1.0	-0.36	-0.44	-0.45	0.37	0.37	0.38	-0.09
Common Stock Shares Outstanding	0.41	0.82	0.82	0.91	0.26	-0.19	-0.29	-0.64	0.21	0.36	0.12	0.37		-0.33	0.58	0.53	0.03	-0.19	0.4	0.03	-0.2	-0.62	0.51	0.52	0.39	-0.43
Non Current Liabilities Total	-0.62	-0.22	-0.45	-0.46	-0.75	-0.34	0.63	0.4	-0.44	-0.64	-0.27	-0.63	-0.33		-0.38	-0.55	0.92	-0.34	-0.63	-0.12	0.87	0.67	-0.56	-0.57	0.2	0.32
Other Current Assets	0.7	0.4	0.32	0.42	0.64	-0.15	-0.55	-0.23	0.2	0.55	0.57	0.56	0.58	-0.38		0.44	-0.25	-0.15	0.63	-0.09	-0.26	-0.5	0.31	0.31	0.34	-0.11
Other Stockholder Equity	0.33	0.56	0.46	0.45	0.38	0.04	-0.34	-0.88	-0.03	0.35	0.02	0.35	0.53	-0.55	0.44		-0.42	0.04	0.38	0.04	-0.39	-0.7	0.86	0.86	0.0	-0.73
Total Liab	-0.53	0.05	-0.09	-0.08	-0.73	-0.35	0.56	0.19	-0.33	-0.54	-0.3	-0.53	0.03	0.92	-0.25	-0.42		-0.35	-0.52	-0.16	0.79	0.51	-0.39	-0.38	0.36	0.16
Property Plant And Equipment Gross	0.21	-0.04	0.23	0.09	0.28	1.0	-0.43	0.06	0.67	0.42	-0.38	0.41	-0.19	-0.34	-0.15	0.04	-0.35		0.37	-0.58	-0.32	0.24	0.19	0.19	0.17	-0.11
Total Current Assets	0.97	0.39	0.4	0.42	0.93	0.37	-0.98	-0.09	0.65	0.99	0.39	1.0	0.4	-0.63	0.63	0.38	-0.52	0.37		-0.35	-0.45	-0.47	0.37	0.38	0.4	-0.09
Short Term Debt	-0.23	-0.03	-0.2	-0.07	-0.14	-0.58	0.34	-0.15	-0.33	-0.34	0.27	-0.36	0.03	-0.12	-0.09	0.04	-0.16	-0.58	-0.35		-0.17	-0.43	0.05	0.06	-0.68	-0.04
Short Term Investments	-0.48	0.06	-0.43	-0.42	-0.6	-0.32	0.49	0.3	-0.41	-0.5	-0.33	-0.44	-0.2	0.87	-0.26	-0.39	0.79	-0.32	-0.45	-0.17		0.59	-0.45	-0.45	0.3	0.18
Non Currrent Assets Other	-0.53	-0.45	-0.47	-0.56	-0.55	0.24	0.44	0.64	-0.18	-0.47	-0.43	-0.45	-0.62	0.67	-0.5	-0.7	0.51	0.24	-0.47	-0.43	0.59		-0.68	-0.69	0.24	0.45
Common Stock Total Equity	0.28	0.56	0.64	0.57	0.33	0.19	-0.36	-0.83	0.24	0.38	-0.19	0.37	0.51	-0.56	0.31	0.86	-0.39	0.19	0.37	0.05	-0.45	-0.68		1.0	-0.08	-0.87
Common Stock	0.28	0.56	0.65	0.58	0.32	0.19	-0.36	-0.84	0.24	0.38	-0.2	0.37	0.52	-0.57	0.31	0.86	-0.38	0.19	0.38	0.06	-0.45	-0.69	1.0		-0.08	-0.87
Net Tangible Assets	0.34	0.47	0.3	0.31	0.18	0.17	-0.36	0.12	0.3	0.36	-0.03	0.38	0.39	0.2	0.34	0.0	0.36	0.17	0.4	-0.68	0.3	0.24	-0.08	-0.08		0.15
Retained Earnings Total Equity	0.05	-0.51	-0.57	-0.46	0.03	-0.11	0.05	0.86	0.01	-0.08	0.53	-0.09	-0.43	0.32	-0.11	-0.73	0.16	-0.11	-0.09	-0.04	0.18	0.45	-0.87	-0.87	0.15

Click cells to compare fundamentals

Immunic Account Relationship Matchups

Immunic fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	66.0M	167.9M	139.1M	127.8M	54.3M	81.3M
Other Current Liab	343K	4.4M	7.2M	8.2M	18.9M	19.9M
Total Current Liabilities	7.1M	8.4M	11.4M	13.1M	24.7M	26.0M
Total Stockholder Equity	58.4M	158.8M	127.1M	113.7M	28.9M	27.5M
Property Plant And Equipment Net	713K	1.1M	1.1M	1.8M	1.8M	1.4M
Net Debt	(28.8M)	(126.8M)	(86.3M)	(105.2M)	(45.3M)	(47.6M)
Retained Earnings	(59.9M)	(103.9M)	(196.9M)	(317.3M)	(410.9M)	(390.3M)
Accounts Payable	2.4M	3.7M	3.7M	4.3M	5.1M	3.9M
Cash	29.4M	127.5M	86.9M	106.7M	46.7M	64.0M
Non Current Assets Total	33.7M	34.1M	34.1M	1.9M	1.8M	1.7M
Cash And Short Term Investments	29.4M	127.5M	86.9M	116.4M	46.7M	66.0M
Common Stock Shares Outstanding	7.7M	15.7M	23.7M	31.8M	44.3M	46.5M
Liabilities And Stockholders Equity	66.0M	167.9M	139.1M	127.8M	54.3M	81.3M
Non Current Liabilities Total	520K	679K	584K	992K	639K	607.1K
Other Current Assets	2.9M	6.3M	18.1M	9.5M	5.9M	4.6M
Other Stockholder Equity	53.7M	266.8M	324.2M	427.9M	436.1M	245.3M
Total Liab	7.6M	9.1M	12.0M	14.1M	25.4M	26.6M
Property Plant And Equipment Gross	713K	1.1M	1.1M	1.8M	1.8M	1.4M
Total Current Assets	32.2M	133.7M	105.0M	125.9M	52.5M	70.8M
Accumulated Other Comprehensive Income	(1.4M)	(4.1M)	(252K)	3.0M	3.8M	3.9M
Non Currrent Assets Other	108K	37K	42K	43K	38.7K	36.8K
Net Tangible Assets	25.4M	125.8M	94.1M	113.7M	130.7M	80.6M
Retained Earnings Total Equity	(59.9M)	(103.9M)	(196.9M)	(317.3M)	(285.6M)	(299.8M)
Capital Surpluse	119.6M	266.8M	324.2M	427.9M	492.1M	326.3M
Non Current Liabilities Other	520K	679K	584K	992K	1.1M	1.2M
Property Plant Equipment	80K	203K	1.1M	294K	264.6K	251.4K
Other Assets	37K	42K	943K	43K	49.5K	47.0K
Net Receivables	408K	1.6M	2.2M	2.7M	703K	1.3M
Net Invested Capital	58.4M	158.8M	127.1M	113.7M	28.9M	27.5M
Net Working Capital	25.2M	125.3M	93.6M	112.8M	27.8M	26.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Immunic Stock Analysis

When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immunic Change In Cash vs Capital Expenditures Analysis

Change In Cash vs Capital Expenditures

Change In Cash vs Capital Expenditures Correlation Analysis

Correlation Coefficient

Change In Cash

Capital Expenditures

Immunic fundamental ratios Correlations

Immunic Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Immunic fundamental ratios Accounts

Also Currently Popular

Additional Tools for Immunic Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Cash And Short Term Investments	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.97	Total Assets

Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Total Current Assets	- 0.98	Net Debt
Net Debt	- 0.95	Total Assets
Net Debt	- 0.94	Total Stockholder Equity
Other Stockholder Equity	- 0.88	Retained Earnings